PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35440680-0 2022 Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection. Mitoxantrone 0-12 surface glycoprotein Severe acute respiratory syndrome coronavirus 2 41-46 35440680-4 2022 Here, we show that Mitoxantrone, an FDA-approved topoisomerase inhibitor, targets a heparan sulfate-spike complex to compromise the fusogenic function of spike in viral entry. Mitoxantrone 19-31 surface glycoprotein Severe acute respiratory syndrome coronavirus 2 100-105 35440680-4 2022 Here, we show that Mitoxantrone, an FDA-approved topoisomerase inhibitor, targets a heparan sulfate-spike complex to compromise the fusogenic function of spike in viral entry. Mitoxantrone 19-31 surface glycoprotein Severe acute respiratory syndrome coronavirus 2 154-159